These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3402306)

  • 1. Is HbA1 measurement superfluous in NIDDM?
    McCance DR; Ritchie CM; Kennedy L
    Diabetes Care; 1988 Jun; 11(6):512-4. PubMed ID: 3402306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of glycosylated hemoglobin (HbA1) and fasting blood glucose in normal subjects and in patients with diabetes mellitus].
    Matsubara LS; Anselmo MA; de Paiva SA; Lima LC; Machado PE; Curi PR
    AMB Rev Assoc Med Bras; 1985; 31(11-12):227-31. PubMed ID: 3879703
    [No Abstract]   [Full Text] [Related]  

  • 3. [The correlation of glycohemoglobin (HbA1) with the parameters of blood glucose control during the treatment of diabetes mellitus].
    Khristov V; Nikolov M
    Vutr Boles; 1989; 28(6):48-52. PubMed ID: 2517370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients.
    Rao GM; Morghom LO; Abukhris AA; Mansori SS; Alphgih FA; Ragale LY
    Trop Geogr Med; 1986 Dec; 38(4):391-7. PubMed ID: 3810843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic changes in the blood glucose, glycosylated hemoglobin and glycosylated serum protein values in patients with diabetes mellitus].
    Kalpazanova N; Dosheva I; Klechkova L
    Vutr Boles; 1987; 26(6):107-10. PubMed ID: 3439144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of glucose and glycosylated haemoglobin in Saudi diabetic patients.
    Ajabnoor MA; Laajam MA
    Trop Geogr Med; 1987 Jul; 39(3):276-80. PubMed ID: 3433344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parameters of altered plasma glucose levels during short intervals in diabetic patients.
    Inoue W; Tomino Y; Miura M; Yagame M; Watanabe S; Tamura S; Kaneshige H; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Mar; 11(1):67-70. PubMed ID: 3810694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study on the levels of glycosylated hemoglobin and fasting plasma glucose in diabetics].
    Xiang KS
    Zhonghua Yi Xue Za Zhi; 1985 Aug; 65(8):449-53. PubMed ID: 3931870
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of blood glucose and haemoglobin A1 levels in diabetic subjects.
    Prendergast C; Smyth O; Murray F; Cunningham SK; McKenna TJ
    Ir J Med Sci; 1994 May; 163(5):233-5. PubMed ID: 8045728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.
    Liu QZ; Pettitt DJ; Hanson RL; Charles MA; Klein R; Bennett PH; Knowler WC
    Diabetologia; 1993 May; 36(5):428-32. PubMed ID: 8314447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemoglobin A1 (HbA1) determination in Nigerian diabetics.
    Famuyiwa OO; Ogunmekan GO; Osotimehin BO
    Afr J Med Med Sci; 1983 Mar; 12(1):29-35. PubMed ID: 6314789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany.
    Heinemann L; Deiss D; Siegmund T; Schlüter S; Naudorf M; von Sengbusch S; Lange K; Freckmann G
    Exp Clin Endocrinol Diabetes; 2018 Jul; 126(7):411-428. PubMed ID: 29975980
    [No Abstract]   [Full Text] [Related]  

  • 15. Reexamining metrics for glucose control.
    Rubinow KB; Hirsch IB
    JAMA; 2011 Mar; 305(11):1132-3. PubMed ID: 21406652
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemoglobin A1 in cirrhosis of the liver.
    Nomura Y; Nanjo K; Miyano M; Kikuoka H; Kuriyama S; Maeda M; Miyamura K
    Diabetes Res; 1989 Aug; 11(4):177-80. PubMed ID: 2625033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aiming for the best control of glycemia in patients with heart failure and type 2 diabetes the "sweet spot".
    Weinrauch LA; Lewis EF
    J Am Coll Cardiol; 2009 Jul; 54(5):429-31. PubMed ID: 19628118
    [No Abstract]   [Full Text] [Related]  

  • 18. Self-Monitoring of Blood Glucose.
    Garg SK; Hirsch IB
    Diabetes Technol Ther; 2019 Feb; 21(S1):S4-S12. PubMed ID: 30785324
    [No Abstract]   [Full Text] [Related]  

  • 19. Self-Monitoring of Blood Glucose.
    Garg SK; Hirsch IB
    Diabetes Technol Ther; 2018 Feb; 20(S1):S3-S12. PubMed ID: 29437471
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glycosylated hemoglobin and the evaluation of control in ambulatory diabetic patients].
    Roy L; Havrankova J; Bannon P; Matte R; Bélanger R; D'Amour P
    Union Med Can; 1983 Sep; 112(9):806-9. PubMed ID: 6649182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.